Pharma manufacturers/companies spend thousands of dollars in identifying high-opportunity prescribers to prioritize and optimize their sales efforts. With the help of our AI-driven framework, we calculate Favourability Score for each HCP and identify prescribers with highest opportunities.
Manufacturers using our approach, for identifying and targeting high-opportunity HCPs, have seen over a 15% increase in gross profit. Read our case study to have a detailed overview of our methodologies and approaches used for both: drug pre-launch and post-launch scenarios.
